HEADER TRANSCRIPTION 05-APR-15 4Z6H TITLE CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN IN COMPLEX WITH A VALEROLACTAM TITLE 2 QUINOLONE LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 9; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 14-134; COMPND 5 SYNONYM: RHABDOMYOSARCOMA ANTIGEN MU-RMS-40.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD9, UNQ3040/PRO9856; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS LYSINE-ACETYLATED HISTONE BINDING, CHROMATIN REGULATOR, KEYWDS 2 TRANSCRIPTION, BROMODOMAIN, STRUCTURAL GENOMICS, STRUCTURAL GENOMICS KEYWDS 3 CONSORTIUM, SGC EXPDTA X-RAY DIFFRACTION AUTHOR C.TALLANT,STRUCTURAL GENOMICS CONSORTIUM (SGC),P.G.K.CLARK, AUTHOR 2 L.C.C.VIEIRA,T.KROJER,G.NUNEZ-ALONSO,S.PICAUD,O.FEDOROV,D.J.DIXON, AUTHOR 3 F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS,C.BOUNTRA,P.E.BRENNAN,S.KNAPP REVDAT 2 10-JAN-24 4Z6H 1 REMARK REVDAT 1 20-MAY-15 4Z6H 0 JRNL AUTH P.G.CLARK,L.C.VIEIRA,C.TALLANT,O.FEDOROV,D.C.SINGLETON, JRNL AUTH 2 C.M.ROGERS,O.P.MONTEIRO,J.M.BENNETT,R.BARONIO,S.MULLER, JRNL AUTH 3 D.L.DANIELS,J.MENDEZ,S.KNAPP,P.E.BRENNAN,D.J.DIXON JRNL TITL LP99: DISCOVERY AND SYNTHESIS OF THE FIRST SELECTIVE BRD7/9 JRNL TITL 2 BROMODOMAIN INHIBITOR. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 54 6217 2015 JRNL REFN ESSN 1521-3773 JRNL PMID 25864491 JRNL DOI 10.1002/ANIE.201501394 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0073 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 24360 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1283 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1755 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE SET COUNT : 85 REMARK 3 BIN FREE R VALUE : 0.3360 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1835 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 68 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.71 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.97000 REMARK 3 B22 (A**2) : -2.60000 REMARK 3 B33 (A**2) : 0.63000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.138 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.695 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1923 ; 0.017 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1888 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2583 ; 1.717 ; 1.996 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4359 ; 0.951 ; 3.005 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 224 ; 4.620 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 80 ;37.505 ;23.250 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 363 ;16.203 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;17.507 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 270 ; 0.118 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2082 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 440 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 902 ; 2.769 ; 3.046 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 901 ; 2.761 ; 3.047 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1124 ; 3.695 ; 4.546 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1125 ; 3.695 ; 4.546 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1021 ; 3.326 ; 3.517 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1022 ; 3.325 ; 3.520 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1460 ; 5.034 ; 5.149 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2278 ; 7.567 ;26.659 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2261 ; 7.574 ;26.570 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 22 B 134 REMARK 3 ORIGIN FOR THE GROUP (A): 99.1300 145.6746 8.0317 REMARK 3 T TENSOR REMARK 3 T11: 0.2684 T22: 0.0143 REMARK 3 T33: 0.0848 T12: 0.0031 REMARK 3 T13: -0.0650 T23: 0.0185 REMARK 3 L TENSOR REMARK 3 L11: 0.5550 L22: 2.3305 REMARK 3 L33: 2.1229 L12: -0.1740 REMARK 3 L13: -0.1207 L23: -0.4926 REMARK 3 S TENSOR REMARK 3 S11: -0.1387 S12: -0.0612 S13: 0.0493 REMARK 3 S21: -0.0145 S22: 0.0211 S23: 0.0689 REMARK 3 S31: -0.3269 S32: 0.0634 S33: 0.1175 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 22 B 134 REMARK 3 ORIGIN FOR THE GROUP (A): 90.3242 179.6328 5.7984 REMARK 3 T TENSOR REMARK 3 T11: 0.3238 T22: 0.3573 REMARK 3 T33: 0.0514 T12: 0.2450 REMARK 3 T13: -0.0283 T23: -0.1002 REMARK 3 L TENSOR REMARK 3 L11: 2.1892 L22: 5.7408 REMARK 3 L33: 0.4947 L12: -1.0529 REMARK 3 L13: 0.6782 L23: 0.8665 REMARK 3 S TENSOR REMARK 3 S11: 0.1838 S12: 0.4690 S13: -0.2921 REMARK 3 S21: 0.4920 S22: -0.0679 S23: 0.1213 REMARK 3 S31: 0.2025 S32: 0.2276 S33: -0.1159 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4Z6H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208687. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25694 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 28.970 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.03300 REMARK 200 R SYM (I) : 0.01400 REMARK 200 FOR THE DATA SET : 25.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.73500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3HME REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M PCB PH 8, 30% PEG1K, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.61650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 62.61000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.61650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 62.61000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 338 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 12 REMARK 465 MET A 13 REMARK 465 LEU A 14 REMARK 465 LYS A 15 REMARK 465 LEU A 16 REMARK 465 SER A 17 REMARK 465 ALA A 18 REMARK 465 GLU A 19 REMARK 465 ASN A 20 REMARK 465 GLU A 21 REMARK 465 SER B 12 REMARK 465 MET B 13 REMARK 465 LEU B 14 REMARK 465 LYS B 15 REMARK 465 LEU B 16 REMARK 465 SER B 17 REMARK 465 ALA B 18 REMARK 465 GLU B 19 REMARK 465 ASN B 20 REMARK 465 GLU B 21 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 133 CG SD CE REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 HIS B 115 CA CB CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 94 CB - CG - OD2 ANGL. DEV. = -6.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4L2 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4L2 B 201 DBREF 4Z6H A 14 134 UNP Q9H8M2 BRD9_HUMAN 14 134 DBREF 4Z6H B 14 134 UNP Q9H8M2 BRD9_HUMAN 14 134 SEQADV 4Z6H SER A 12 UNP Q9H8M2 EXPRESSION TAG SEQADV 4Z6H MET A 13 UNP Q9H8M2 EXPRESSION TAG SEQADV 4Z6H SER B 12 UNP Q9H8M2 EXPRESSION TAG SEQADV 4Z6H MET B 13 UNP Q9H8M2 EXPRESSION TAG SEQRES 1 A 123 SER MET LEU LYS LEU SER ALA GLU ASN GLU SER THR PRO SEQRES 2 A 123 ILE GLN GLN LEU LEU GLU HIS PHE LEU ARG GLN LEU GLN SEQRES 3 A 123 ARG LYS ASP PRO HIS GLY PHE PHE ALA PHE PRO VAL THR SEQRES 4 A 123 ASP ALA ILE ALA PRO GLY TYR SER MET ILE ILE LYS HIS SEQRES 5 A 123 PRO MET ASP PHE GLY THR MET LYS ASP LYS ILE VAL ALA SEQRES 6 A 123 ASN GLU TYR LYS SER VAL THR GLU PHE LYS ALA ASP PHE SEQRES 7 A 123 LYS LEU MET CYS ASP ASN ALA MET THR TYR ASN ARG PRO SEQRES 8 A 123 ASP THR VAL TYR TYR LYS LEU ALA LYS LYS ILE LEU HIS SEQRES 9 A 123 ALA GLY PHE LYS MET MET SER LYS GLU ARG LEU LEU ALA SEQRES 10 A 123 LEU LYS ARG SER MET SER SEQRES 1 B 123 SER MET LEU LYS LEU SER ALA GLU ASN GLU SER THR PRO SEQRES 2 B 123 ILE GLN GLN LEU LEU GLU HIS PHE LEU ARG GLN LEU GLN SEQRES 3 B 123 ARG LYS ASP PRO HIS GLY PHE PHE ALA PHE PRO VAL THR SEQRES 4 B 123 ASP ALA ILE ALA PRO GLY TYR SER MET ILE ILE LYS HIS SEQRES 5 B 123 PRO MET ASP PHE GLY THR MET LYS ASP LYS ILE VAL ALA SEQRES 6 B 123 ASN GLU TYR LYS SER VAL THR GLU PHE LYS ALA ASP PHE SEQRES 7 B 123 LYS LEU MET CYS ASP ASN ALA MET THR TYR ASN ARG PRO SEQRES 8 B 123 ASP THR VAL TYR TYR LYS LEU ALA LYS LYS ILE LEU HIS SEQRES 9 B 123 ALA GLY PHE LYS MET MET SER LYS GLU ARG LEU LEU ALA SEQRES 10 B 123 LEU LYS ARG SER MET SER HET 4L2 A 201 20 HET 4L2 B 201 20 HETNAM 4L2 1,4-DIMETHYL-7-(2-OXOPIPERIDIN-1-YL)QUINOLIN-2(1H)-ONE FORMUL 3 4L2 2(C16 H18 N2 O2) FORMUL 5 HOH *68(H2 O) HELIX 1 AA1 THR A 23 LYS A 39 1 17 HELIX 2 AA2 GLY A 56 ILE A 61 1 6 HELIX 3 AA3 ASP A 66 ALA A 76 1 11 HELIX 4 AA4 SER A 81 ASN A 100 1 20 HELIX 5 AA5 THR A 104 MET A 121 1 18 HELIX 6 AA6 SER A 122 MET A 133 1 12 HELIX 7 AA7 THR B 23 LYS B 39 1 17 HELIX 8 AA8 GLY B 56 ILE B 61 1 6 HELIX 9 AA9 ASP B 66 ALA B 76 1 11 HELIX 10 AB1 SER B 81 ASN B 100 1 20 HELIX 11 AB2 THR B 104 MET B 121 1 18 HELIX 12 AB3 SER B 122 MET B 133 1 12 SITE 1 AC1 9 GLY A 43 PHE A 44 PHE A 45 PHE A 47 SITE 2 AC1 9 VAL A 49 ASN A 100 TYR A 106 HOH A 307 SITE 3 AC1 9 GLU B 124 SITE 1 AC2 8 GLY B 43 PHE B 44 PHE B 45 VAL B 49 SITE 2 AC2 8 ILE B 53 ASN B 100 TYR B 106 HOH B 303 CRYST1 71.233 125.220 29.775 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014038 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007986 0.000000 0.00000 SCALE3 0.000000 0.000000 0.033585 0.00000